Xiaoxia Qian
Sheng Jing Hospital(CN)
Publications by Year
Research Areas
Synthesis and Biological Evaluation, Diabetes Treatment and Management, Peptidase Inhibition and Analysis, Coccidia and coccidiosis research, Neuropeptides and Animal Physiology
Most-Cited Works
- → Dipeptidyl Peptidase IV Inhibition for the Treatment of Type 2 Diabetes(2005)490 cited
- → Omarigliptin (MK-3102): A Novel Long-Acting DPP-4 Inhibitor for Once-Weekly Treatment of Type 2 Diabetes(2014)167 cited
- → Synthesis and SAR studies of very potent imidazopyridine antiprotozoal agents(2006)97 cited
- → Chromophore-Modified Bis-Naphthalimides: Synthesis and Antitumor Activity of Bis-Dibenz[de,h]isoquinoline-1,3-diones(1997)55 cited
- → Synthesis and SAR of 2,3-diarylpyrrole inhibitors of parasite cGMP-dependent protein kinase as novel anticoccidial agents(2005)52 cited
- → (3R)-4-[(3R)-3-Amino-4-(2,4,5-trifluorophenyl)butanoyl]-3-(2,2,2-trifluoroethyl)-1,4-diazepan-2-one, a selective dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes(2006)48 cited
- → Novel tetrahydropyran analogs as dipeptidyl peptidase IV inhibitors: Profile of clinical candidate (2R,3S,5R)-2-(2,5-difluorophenyl)-5-[2-(methylsulfonyl)-2,6-dihydropyrrolo[3,4-c]pyrazol-5(4H)-yl]tetrahydro-2H-pyran-3-amine (23)(2013)39 cited
- → Optimization of 1,4-diazepan-2-one containing dipeptidyl peptidase IV inhibitors for the treatment of type 2 diabetes(2007)32 cited
- → Synthesis and SAR of benzyl and phenoxymethylene oxadiazole benzenesulfonamides as selective β3 adrenergic receptor agonist antiobesity agents(2000)27 cited
- → Synthesis and SAR studies of potent imidazopyridine anticoccidial agents(2007)26 cited